Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells.

Abstract:

:Iodide uptake in the thyroid and breast is mediated by the sodium/iodide symporter (NIS). NIS activation is used for radioiodide imaging and therapeutic ablation of thyroid carcinoma. NIS is expressed in >70% of breast cancers but at a level insufficient for radioiodine treatment. All-trans retinoic acid (tRA) induces NIS gene expression and functional iodide uptake in human breast cancer cell lines and mouse breast cancer models. tRA usually regulates gene expression by direct interaction of RA receptor (RAR) with a target gene, but it can also act through nongenomic pathways. We report a direct influence of tRA treatment on the phosphoinositide 3-kinase (PI3K) signal transduction pathway that mediates tRA-induced NIS expression in MCF-7 breast cancer cells. MCF-7 cells express all three RAR isoforms, alpha, beta, and gamma, and RXRalpha. We previously identified RARbeta and RXRalpha as important for NIS induction by tRA. Treatment with LY294002, the PI3K inhibitor, or p85alpha knockdown with siRNA abolished tRA-induced NIS expression. Immunoprecipitation experiments and glutathione S-transferase pull-down assay showed a direct interaction between RARbeta2, RXRalpha, and p85alpha. RA also induced rapid activation of Akt in MCF-7 cells. Treatment with an Akt inhibitor or Akt knockdown with siRNA reduced NIS expression. These findings indicate that RA induction of NIS in MCF-7 cells is mediated by rapid activation of the PI3K pathway and involves direct interaction with RAR and retinoid X receptor. Defining these mechanisms should lead to methods to further enhance NIS expression, as well as retinoid targets that influence growth and differentiation of breast cancer.

journal_name

Cancer Res

journal_title

Cancer research

authors

Ohashi E,Kogai T,Kagechika H,Brent GA

doi

10.1158/0008-5472.CAN-08-3234

subject

Has Abstract

pub_date

2009-04-15 00:00:00

pages

3443-50

issue

8

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-08-3234

journal_volume

69

pub_type

杂志文章
  • Effects of the immunosuppressive drug niridazole in isogeneic and allogeneic mouse tumor systems in vivo.

    abstract::In both isogeneic (Sarcoma 1 in A/JAX mice) and allogeneic (Sarcoma 180 in C57BL/6 mice) mouse tumor systems, treatment of the tumor-bearing mice with niridazole, an antiprarasitic drug, known to be a potent suppressor of cell mediated but not humoral immunity caused enhancement of metastases to regional popliteal nod...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Deodhar SD,Lee VW,Chiang T,Mahmoud AF,Watten KS

    更新日期:1976-09-01 00:00:00

  • DNA repair related to multiple skin cancers and drug use.

    abstract::Defective repair of sunlight-induced DNA photodamage, coupled with an unusually high occurrence of multiple primary basal cell carcinomas (BCCs), is the major characteristic of xeroderma pigmentosum. Our recent work has indicated that this etiological paradigm may apply to skin cancer patients without an apparent here...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wei Q,Matanoski GM,Farmer ER,Hedayati MA,Grossman L

    更新日期:1994-01-15 00:00:00

  • Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides.

    abstract::Benz(a)anthracene (BA) and its five possible trans-dihydrodiols were evaluated for determination of their skin tumor-initiating activity and their mutagenic activity in Chinese hamster V79 cells. In addition, the skin tumor-initiating abilities of five diol-epoxides of BA were tested. Results showed (+/-)-trans-3,4-di...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Slaga TJ,Huberman E,Selkirk JK,Harvey RG,Bracken WM

    更新日期:1978-06-01 00:00:00

  • A Novel Mechanism to Induce BRCAness in Cancer Cells.

    abstract::Cancer cells with germline deleterious mutations of BRCA1 or BRCA2 are deficient in homologous recombination repair and therefore sensitive to PARP inhibitor treatment. However, wild-type BRCA1/2-expressing cells with defects in other DNA damage repair pathway components may also exhibit "BRCAness," which in combinati...

    journal_title:Cancer research

    pub_type: 评论,杂志文章

    doi:10.1158/0008-5472.CAN-20-1451

    authors: Cai C

    更新日期:2020-07-15 00:00:00

  • A Quantitative System for Studying Metastasis Using Transparent Zebrafish.

    abstract::Metastasis is the defining feature of advanced malignancy, yet remains challenging to study in laboratory environments. Here, we describe a high-throughput zebrafish system for comprehensive, in vivo assessment of metastatic biology. First, we generated several stable cell lines from melanomas of transgenic mitfa-BRAF...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3319

    authors: Heilmann S,Ratnakumar K,Langdon E,Kansler E,Kim I,Campbell NR,Perry E,McMahon A,Kaufman C,van Rooijen E,Lee W,Iacobuzio-Donahue C,Hynes R,Zon L,Xavier J,White RM

    更新日期:2015-10-15 00:00:00

  • Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.

    abstract::Cancers with chromosomal instability (CIN) are held to be aneuploid/polyploid with multiple large-scale gains/deletions, but the processes underlying CIN are unclear and different types of CIN might exist. We investigated colorectal cancer cell lines using array-comparative genomic hybridization (CGH) for copy number ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3285

    authors: Gaasenbeek M,Howarth K,Rowan AJ,Gorman PA,Jones A,Chaplin T,Liu Y,Bicknell D,Davison EJ,Fiegler H,Carter NP,Roylance RR,Tomlinson IP

    更新日期:2006-04-01 00:00:00

  • Genome-wide hypomethylation in hepatocellular carcinogenesis.

    abstract::Aberrant genome-wide hypomethylation has been thought to be related to tumorigenesis. However, its mechanism and implications in hepatocellular carcinogenesis remain to be elucidated. Samples of hepatoma (hepatocellular carcinoma, HCC) and paired non-HCC liver tissues were obtained from 17 HCC patients. Normal liver t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lin CH,Hsieh SY,Sheen IS,Lee WC,Chen TC,Shyu WC,Liaw YF

    更新日期:2001-05-15 00:00:00

  • 8-Chloroadenosine 3',5'-monophosphate inhibits the growth of Chinese hamster ovary and Molt-4 cells through its adenosine metabolite.

    abstract::8-Chloroadenosine 3',5'-monophosphate has been reported to inhibit growth of various mammalian cell lines at micromolar concentrations. We have used Chinese hamster ovary cell lines with mutated cyclic AMP-dependent protein kinase or altered cyclic nucleotide metabolism to show that a metabolite, 8-chloroadenosine, is...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Van Lookeren Campagne MM,Villalba Díaz F,Jastorff B,Kessin RH

    更新日期:1991-03-15 00:00:00

  • Expression of early growth response genes in human prostate cancer.

    abstract::Early growth-response (EGR) genes are nuclear transcription factors that are implicated in regulating cell proliferation. Because these genes show divergent expression in various human tumors, we sought to determine their expression in nonmalignant and malignant prostate tissues. Total RNA extracted from prostate tiss...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Eid MA,Kumar MV,Iczkowski KA,Bostwick DG,Tindall DJ

    更新日期:1998-06-01 00:00:00

  • The inhibition of ribosomal RNA synthesis and maturation in Novikoff hepatoma cells by 5-fluorouridine.

    abstract::The inhibition of ribosomal RNA (rRNA) maturation by 5-fluorouridine (FUrd) in Novikoff hepatoma cells appears to depend upon the incorporation of the analog into the 45 S rRNA precursor. Precursor synthesized in the presence of FUrd is not processed into mature rRNA, but precursor synthesized in the absence of the an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wilkinson DS,Tlsty TD,Hanas RJ

    更新日期:1975-11-01 00:00:00

  • NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.

    abstract::Phosphatidylinositol-3-kinase (PI3K) pathway deregulation is a common event in human cancer, either through inactivation of the tumor suppressor phosphatase and tensin homologue deleted from chromosome 10 or activating mutations of p110-alpha. These hotspot mutations result in oncogenic activity of the enzyme and cont...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1385

    authors: Serra V,Markman B,Scaltriti M,Eichhorn PJ,Valero V,Guzman M,Botero ML,Llonch E,Atzori F,Di Cosimo S,Maira M,Garcia-Echeverria C,Parra JL,Arribas J,Baselga J

    更新日期:2008-10-01 00:00:00

  • Potent graft antitumor effect in natural killer-resistant disseminated tumors by transplantation of interleukin 2-activated syngeneic bone marrow in mice.

    abstract::The current study is a continuation of our previous work showing that bone marrow activated in interleukin 2 has antitumor and antiviral activity in vitro. The antitumor efficacy of IL-2-activated bone marrow cells in vivo was assessed here. Our results indicated that bone marrow cells activated in IL-2 for 3 days (AB...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Agah R,Malloy B,Kerner M,Girgis E,Bean P,Twomey P,Mazumder A

    更新日期:1989-11-01 00:00:00

  • Specific Targeting of MTAP-Deleted Tumors with a Combination of 2'-Fluoroadenine and 5'-Methylthioadenosine.

    abstract::Homozygous deletion of the methylthioadenosine phosphorylase (MTAP) gene is a frequent event in a wide variety of human cancers and is a possible molecular target for therapy. One potential therapeutic strategy to target MTAP-deleted tumors involves combining toxic purine analogues such as 6'-thioguanine (6TG) or 2'-f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-0814

    authors: Tang B,Lee HO,An SS,Cai KQ,Kruger WD

    更新日期:2018-08-01 00:00:00

  • Chromosomal fragile site FRA16D and DNA instability in cancer.

    abstract::It has been proposed that common aphidicolin-inducible fragile sites, in general, predispose to specific chromosomal breakage associated with deletion, amplification, and/or translocation in certain forms of cancer. Although this appears to be the case for the fragile site FRA3B and may be the case for FRA7G, it is no...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mangelsdorf M,Ried K,Woollatt E,Dayan S,Eyre H,Finnis M,Hobson L,Nancarrow J,Venter D,Baker E,Richards RI

    更新日期:2000-03-15 00:00:00

  • Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2.

    abstract::Neurofibromatosis type 2 (NF2) is a dominantly inherited cancer disorder caused by mutations at the NF2 gene locus. Merlin, the protein product of the NF2 gene, has been shown to negatively regulate Rac1 signaling by inhibiting its downstream effector kinases, the p21-activated kinases (Pak). Given the implication of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0866

    authors: Yi C,Wilker EW,Yaffe MB,Stemmer-Rachamimov A,Kissil JL

    更新日期:2008-10-01 00:00:00

  • Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.

    abstract::Mithramycin (MIT) and tolfenamic acid (TA) inhibit the activity of the transcription factor Sp1. In the present study, we investigated whether pancreatic cancer treatment with a combination of these compounds has a synergistic effect on Sp1 activity, tumor growth, and their underlying response mechanisms. Treatment of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3282

    authors: Jia Z,Gao Y,Wang L,Li Q,Zhang J,Le X,Wei D,Yao JC,Chang DZ,Huang S,Xie K

    更新日期:2010-02-01 00:00:00

  • A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.

    abstract::A chimeric CYCLIN D1-TROP2 mRNA was isolated from human ovarian and mammary cancer cells. The CYCLIN D1-TROP2 mRNA was shown to be a potent oncogene as it transforms naïve, primary cells in vitro and induces aggressive tumor growth in vivo in cooperation with activated RAS. Silencing of the chimeric mRNA inhibits the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6135

    authors: Guerra E,Trerotola M,Dell' Arciprete R,Bonasera V,Palombo B,El-Sewedy T,Ciccimarra T,Crescenzi C,Lorenzini F,Rossi C,Vacca G,Lattanzio R,Piantelli M,Alberti S

    更新日期:2008-10-01 00:00:00

  • Production of autoimmune gastric hyperplasia in mice by the transfer of spleen cells from thymectomized donors.

    abstract::Previous work showed that mice that had been thymectomized at 3 days of age tended, in later life, to develop a hyperplastic autoimmune gastritis and were also hypersusceptible to sarcogenesis by low dosages of 3-methylcholanthrene. In the present work, it was found that the hyperplastic autoimmune gastritis could be ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Prehn LM

    更新日期:1986-07-01 00:00:00

  • EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style.

    abstract::Eph tyrosine kinases instruct cell for a repulsive behavior, regulating cell shape, adhesion, and motility. Beside its role during embryogenesis, neurogenesis, and angiogenesis, EphA2 kinase is frequently up-regulated in tumor cells of different histotypes, including prostate, breast, colon, and lung carcinoma, as wel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1845

    authors: Parri M,Taddei ML,Bianchini F,Calorini L,Chiarugi P

    更新日期:2009-03-01 00:00:00

  • Beta-catenin mutations in biliary tract cancers: a population-based study in China.

    abstract::beta-Catenin is an ubiquitously expressed cytoplasmic protein that has a crucial role in both cadherin-mediated cell-cell adhesion and as a downstream signaling molecule in the wingless/Wnt pathway. Activating mutations in exon 3 of the beta-catenin gene, at the phosphorylation sites for ubiquitination and degradation...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rashid A,Gao YT,Bhakta S,Shen MC,Wang BS,Deng J,Fraumeni JF Jr,Hsing AW

    更新日期:2001-04-15 00:00:00

  • The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy.

    abstract::Compelling evidences indicate a key role for regulatory T cells (T(reg)) on the host response to cancer. The Wilms' tumor antigen (WT1) is overexpressed in several human leukemias and thus considered as promising target for development of leukemia vaccine. However, recent studies indicated that the generation of effec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0050

    authors: Lehe C,Ghebeh H,Al-Sulaiman A,Al Qudaihi G,Al-Hussein K,Almohareb F,Chaudhri N,Alsharif F,Al-Zahrani H,Tbakhi A,Aljurf M,Dermime S

    更新日期:2008-08-01 00:00:00

  • Invasive properties of primary pediatric neoplasms in vitro.

    abstract::Primary solid tumors were mechanically and/or enzymatically disassociated, and the resulting suspensions of single cells and small clumps of cells were seeded onto three different substrates, i.e., tissue culture plastic, rat smooth muscle cells (SMCs), and SMC-derived extracellular matrix. Tests of the relative effec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bogenmann E,Mark C,Isaacs H,Neustein HB,De Clerck YA,Laug WE,Jones PA

    更新日期:1983-03-01 00:00:00

  • Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.

    abstract::Malignant changes are often accompanied by alterations in activity and composition of the plasminogen activators (PA). To study the relationship between PA expression and the development of colorectal cancer, we determined urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) activit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: de Bruin PA,Griffioen G,Verspaget HW,Verheijen JH,Lamers CB

    更新日期:1987-09-01 00:00:00

  • Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix.

    abstract::We have recently demonstrated that many cancer cell lines produce a novel trypsinogen isoenzyme called tumor-associated trypsinogen 2 (TAT-2). It was found during a search of the target protease for tumor-associated trypsin inhibitor (TATI). We now show that degradation of subendothelial cell extracellular matrix (ECM...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Koivunen E,Ristimäki A,Itkonen O,Osman S,Vuento M,Stenman UH

    更新日期:1991-04-15 00:00:00

  • Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells.

    abstract::1-beta-D-Arabinofuranosylcytosine (araC) is an effective drug in the i.p. therapy of ovarian carcinoma but little is known of its transport and metabolism in this tumor. Influx of araC at 1 microM into cultured human ovarian carcinoma cells (CI 80-13S) was largely inhibited by nanomolar concentrations of the nucleosid...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jamieson GP,Snook MB,Bradley TR,Bertoncello I,Wiley JS

    更新日期:1989-01-15 00:00:00

  • Kinetics of induction and growth of enzyme-deficient islands involved in hepatocarcinogenesis.

    abstract::A single application of various hepatocarcinogens to rats results in the formation of islands of enzyme-deficient liver cells, which are mainly irreversible and very probably represent the first cellular stage involved in the process of liver cancer formation. Comparison of the island-size distributions obtained for d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Scherer E,Emmelot P

    更新日期:1976-07-01 00:00:00

  • Tumor-derived osteopontin suppresses antitumor immunity by promoting extramedullary myelopoiesis.

    abstract::Extramedullary myelopoiesis occurs commonly in tumor-bearing animals and is known to lead to accumulation of peripheral myeloid-derived suppressor cells (MDSC), which play an important role in immune escape. However, the cellular and molecular mechanisms by which tumors induce extramedullary myelopoiesis are poorly un...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-1482

    authors: Kim EK,Jeon I,Seo H,Park YJ,Song B,Lee KA,Jang Y,Chung Y,Kang CY

    更新日期:2014-11-15 00:00:00

  • Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.

    abstract::Nitric oxide (NO) in nanomolar (nmol/L) concentrations is consistently detected in tumor microenvironment and has been found to promote tumorigenesis. The mechanism by which NO enhances tumor progression is largely unknown. In this study, we investigated the possible mechanisms and identified cellular targets by which...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4623

    authors: Pervin S,Singh R,Hernandez E,Wu G,Chaudhuri G

    更新日期:2007-01-01 00:00:00

  • MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer.

    abstract::Cancers are initiated as a result of changes that occur in the genome. Identification of gains and losses in the structure and expression of tumor-suppressor genes and oncogenes lies at the root of the understanding of cancer cell biology. Here, we show that the mitogen-activated protein kinase (MAPK) MKK3 suppresses ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1310

    authors: MacNeil AJ,Jiao SC,McEachern LA,Yang YJ,Dennis A,Yu H,Xu Z,Marshall JS,Lin TJ

    更新日期:2014-01-01 00:00:00

  • β-catenin contributes to lung tumor development induced by EGFR mutations.

    abstract::The discovery of somatic mutations in EGFR and development of EGFR tyrosine kinase inhibitors (TKI) have revolutionized treatment for lung cancer. However, resistance to TKIs emerges in almost all patients and currently no effective treatment is available. Here, we show that β-catenin is essential for development of E...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0184

    authors: Nakayama S,Sng N,Carretero J,Welner R,Hayashi Y,Yamamoto M,Tan AJ,Yamaguchi N,Yasuda H,Li D,Soejima K,Soo RA,Costa DB,Wong KK,Kobayashi SS

    更新日期:2014-10-15 00:00:00